HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Oxford Acute Myocardial Infarction (OxAMI) Study Selected Research

Oxford Acute Myocardial Infarction (OxAMI) Study Research Topics

Disease

6ST Elevation Myocardial Infarction
01/2022 - 01/2018
3Infarction (Infarctions)
01/2022 - 01/2018
2Heart Failure
01/2022 - 01/2021
2Reperfusion Injury
01/2022 - 01/2018
2Myocardial Infarction
01/2022 - 01/2020
1Myocardial Reperfusion Injury
01/2022
1Thrombosis (Thrombus)
01/2021
1Heart Arrest (Cardiac Arrest)
01/2021
1Cardiovascular Diseases (Cardiovascular Disease)
01/2021
1Ischemia
01/2018
1Mitochondrial Diseases (Mitochondrial Disease)
01/2018
1Stable Angina
01/2018
1Myocardial Ischemia (Ischemic Heart Diseases)
01/2018
1Edema (Dropsy)
01/2018

Drug/Important Bio-Agent (IBA)

1(2S,3S)-oxirane-2,3-dicarboxylic acid 2- (((S)- 1- benzylcarbamoyl- 2- phenyl- ethyl)- amide) 3-((2-(4-hydroxy-phenyl)-ethyl)-amide)IBA
01/2022
1CalciumIBA
01/2022
1Peptide Hydrolases (Proteases)FDA Link
01/2022
1Cathepsin LIBA
01/2022
1omega-Chloroacetophenone (Mace)IBA
01/2021
1Neuropeptide YIBA
01/2019
1Vasoconstrictor AgentsIBA
01/2019
1Succinic Acid (Succinate)IBA
01/2018

Therapy/Procedure

4Percutaneous Coronary Intervention
01/2022 - 01/2018
1Therapeutics
01/2022
1Stents
01/2021
1Aftercare (After-Treatment)
01/2020
1Emergency Treatment
01/2018